Your browser doesn't support javascript.
loading
Naturally Acquired SARS-CoV-2 Immunity Persists for Up to 11 Months Following Infection.
De Giorgi, Valeria; West, Kamille A; Henning, Amanda N; Chen, Leonard N; Holbrook, Michael R; Gross, Robin; Liang, Janie; Postnikova, Elena; Trenbeath, Joni; Pogue, Sarah; Scinto, Tania; Alter, Harvey J; Cantilena, Cathy Conry.
Afiliação
  • De Giorgi V; Department of Transfusion Medicine, National Institutes of Health Clinical Center, Bethesda, Maryland,USA.
  • West KA; Department of Transfusion Medicine, National Institutes of Health Clinical Center, Bethesda, Maryland,USA.
  • Henning AN; Department of Transfusion Medicine, National Institutes of Health Clinical Center, Bethesda, Maryland,USA.
  • Chen LN; Department of Transfusion Medicine, National Institutes of Health Clinical Center, Bethesda, Maryland,USA.
  • Holbrook MR; National Institute of Allergy and Infectious Diseases Integrated Research Facility, National Institutes of Health, Frederick, Maryland,USA.
  • Gross R; National Institute of Allergy and Infectious Diseases Integrated Research Facility, National Institutes of Health, Frederick, Maryland,USA.
  • Liang J; National Institute of Allergy and Infectious Diseases Integrated Research Facility, National Institutes of Health, Frederick, Maryland,USA.
  • Postnikova E; National Institute of Allergy and Infectious Diseases Integrated Research Facility, National Institutes of Health, Frederick, Maryland,USA.
  • Trenbeath J; Department of Transfusion Medicine, National Institutes of Health Clinical Center, Bethesda, Maryland,USA.
  • Pogue S; Department of Transfusion Medicine, National Institutes of Health Clinical Center, Bethesda, Maryland,USA.
  • Scinto T; Department of Transfusion Medicine, National Institutes of Health Clinical Center, Bethesda, Maryland,USA.
  • Alter HJ; Department of Transfusion Medicine, National Institutes of Health Clinical Center, Bethesda, Maryland,USA.
  • Cantilena CC; Department of Transfusion Medicine, National Institutes of Health Clinical Center, Bethesda, Maryland,USA.
J Infect Dis ; 224(8): 1294-1304, 2021 10 28.
Article em En | MEDLINE | ID: mdl-34089610
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Anticorpos Neutralizantes / Imunidade Adaptativa / SARS-CoV-2 / COVID-19 / Anticorpos Antivirais Tipo de estudo: Diagnostic_studies / Observational_studies / Prognostic_studies Limite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Anticorpos Neutralizantes / Imunidade Adaptativa / SARS-CoV-2 / COVID-19 / Anticorpos Antivirais Tipo de estudo: Diagnostic_studies / Observational_studies / Prognostic_studies Limite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article